BLT 0.00% 2.6¢ benitec biopharma limited

Buchi and TLOG

  1. 653 Posts.
    lightbulb Created with Sketch. 10
    Our esteemed BOD member Kevin Buchi's Tetralogic, of which he is CEO and President of the BOD has been on a nosedive for months. Last Wed/Thurs it dropped 70% in one day. There is no reason he should sit on our board. Their main goal is HBV and I don't see how he provides any value to BLT and it's aspirations for the HBV space.

    $6.25 to .28====just another case of creating shareholder value. Note that TLOG was a KSS buy.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.